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The orphan nuclear receptor estrogen-related re-
ceptor a (ERRa; NR3B1) is a key metabolic regu-
lator, but its function in regulating inflammation
remains largely unknown. Here, we demonstrate
that ERRa negatively regulates Toll-like receptor
(TLR)-induced inflammation by promoting Tnfaip3
transcription and fine-tuning of metabolic reprog-
ramming in macrophages. ERRa-deficient (Esrra–/–)
mice showed increased susceptibility to endo-
toxin-induced septic shock, leading to more severe
pro-inflammatory responses than control mice.
ERRa regulated macrophage inflammatory re-
sponses by directly binding the promoter region of
Tnfaip3, a deubiquitinating enzyme in TLR signaling.
In addition, Esrra–/– macrophages showed an
increased glycolysis, but impaired mitochondrial
respiratory function and biogenesis. Further, ERRa
was required for the regulation of NF-kB signaling
by controlling p65 acetylation via maintenance of
NAD+ levels and sirtuin 1 activation. These find-
ings unravel a previously unappreciated role for
ERRa as a negative regulator of TLR-induced in-
flammatory responses through inducing Tnfaip3
transcription and controlling the metabolic reprog-
ramming.80 Immunity 43, 80–91, July 21, 2015 ª2015 Elsevier Inc.INTRODUCTION
Toll-like receptors (TLRs) are the most characterized innate
immune receptors. They play a key role in the recognition of
invading pathogens and the detection of various danger signals,
triggering intracellular signaling cascades that initiate inflamma-
tory and antimicrobial responses (Kawai and Akira, 2011). To
avoid excessive inflammatory responses, TLR signaling path-
ways are tightly controlled by multiple levels of transcriptional
and post-translational regulation (Kawai and Akira, 2011).
Indeed, numerous negative regulators have been identified that
regulate host innate immune signaling pathways, thereby pre-
venting uncontrolled and potentially harmful inflammatory re-
sponses (Kondo et al., 2012). A crucial adaptor of TLR signaling,
TNF receptor-associated factor (TRAF) 6, is targeted by multiple
negative regulators, including A20/TNFAIP3, Cylindromatosis
(CYLD), TANK, and small heterodimer partner (SHP) (Boone
et al., 2004; Kawagoe et al., 2009; Trompouki et al., 2003; Xia
et al., 2013; Yoshida et al., 2005; Yuk et al., 2011).
Estrogen-related receptor a (ERRa), ERRb, and ERRg (NR3B1,
NR3B2, and NR3B3, respectively) are orphan nuclear receptors
that share characteristics with, but are distinct from, ER-a
(NR3A1) and ER-b (NR3A2) (Deblois and Gigue`re, 2013). ERRa
was the first identified orphan nuclear receptor, with a crucial
role in regulating energy metabolism and mitochondrial biogen-
esis (Deblois and Gigue`re, 2011; Villena and Kralli, 2008).
ERRa, like otherERRs (ERRbandERRg), are transcription factors
that translate metabolic signals into specific gene-expression
profiles, to fulfill the energetic demands required for diverse
biological functions (Gigue`re, 2008). Emerging evidence sug-
gests that the ERR family members might have therapeutic po-
tential for the treatment ofmetabolic diseases and cancers (Ariazi
and Jordan, 2006; Deblois and Gigue`re, 2011, 2013). Previous
studies have shown that ERRa contributes to interferon-g-
induced antimicrobial responses to Listeria infection via a mech-
anism involving expression of themitochondrial respiratory chain
machinery and increasedmitochondrial reactive oxygen species
(ROS) generation (Sonoda et al., 2007). In addition, ERRa is
involved in the regulation of metabolism essential for effector
T cell activation and differentiation (Michalek et al., 2011). Recent
studies have indicated that ERRa promotes hepatocellular carci-
noma by enhancing NF-kB activity and the inflammatory re-
sponses (Hong et al., 2013). Another recent study showed that
an ERRg inverse agonist exerts a protective effect against
intracellular microbial infection (Kim et al., 2014). Although these
reports provide insight into the potential role of the ERR family
members in the immune response and inflammation, functional
studies regarding the specific role of each ERR in the regulation
of the immune and inflammatory responses are in their infancy.
In the study described here, we aimed to characterize the
role of ERRa in the regulation of TLR-induced inflammatory
responses.
RESULTS
ERRa Deficiency Exacerbates Systemic Inflammatory
Responses In Vivo, Leading to Increased Mortality
We first examined the role of ERRa in the regulation of systemic
inflammation in vivo. ERRa protein was detected in the liver,
spleen, and bone marrow (BM) in wild-type (WT) mice after intra-
peritoneal injection of lipopolysaccharide (LPS) at 8 hr (data not
shown). To determine whether ERRa deficiency affects suscep-
tibility to systemic inflammation, we challenged Esrra+/+ and
Esrra–/– mice with endotoxin-induced septic shock. As shown
in Figure 1A, the lethality associated with septic shock was
dramatically increased in Esrra/ mice, when compared with
that in Esrra+/+ mice. Consistent with the diminished survival
rates, the levels of pro-inflammatory cytokines increased signif-
icantly in Esrra–/– mice after LPS challenge (Figure 1B). Next, we
assessed the production of pro-inflammatory cytokines, such as
tumor necrosis factor alpha (TNF-a), interleukin 6 (IL-6), and
IL-1b in different tissues (lung, spleen, and liver) in response to
LPS injection. The mRNA expression of Tnf, Il6, and Il1b in
response to LPS challenge was greatly elevated in the lung
and spleen tissues of Esrra–/– mice, compared with the corre-
sponding tissues of Esrra+/+ mice (Figure 1C). In addition, neutro-
phil infiltration was markedly elevated in the lung tissues of
Esrra–/– mice, compared with Esrra+/+ mice, after LPS challenge
(Figure 1D). These results indicate that ERRa attenuates sys-
temic inflammation and reduces lethality in septic shockmodels.
We next explored the contribution of BM–derived ERRa in
endotoxin-induced septic shock and inflammation by using
BM chimeric mice generated from Esrra+/+ and Esrra–/– mice.
The generation of ERRa BM chimeras was performed by the
following adoptive transfer between histocompatible mouse
strains: reconstitution of Esrra–/– mice with Esrra+/+ or Esrra–/–
BM-derived cells, and reconstitution of Esrra+/+ mice with
Esrra–/– or Esrra+/+ BM-derived cells. Gene analysis of ERRashowed the expression of ERRa in peripheral leukocytes from
Esrra+/+ and Esrra–/– mice transplanted with Esrra+/+ mouse-
derived BM cells (data not shown). When the mice were sub-
jected to endotoxin-induced lethal shock, both Esrra+/+ and
Esrra–/– mice transplanted with Esrra+/+ mouse-derived BM cells
had lower expression of Tnf and Il6 mRNA in spleen (Figure 1E),
lower concentrations of TNF and IL-6 in serum (Figure 1F), and
better survival (n = 10; Figure 1G) than in the respective Esrra–/–
BM recipients. These data indicate that Esrra+/+ BM-derived
cells essentially contribute to regulating the sensitivity of animals
to endotoxin-induced lethal shock.
ERRaAttenuates TLR4-Induced Inflammatory Response
by Regulation of NF-kB Signaling in Macrophages
We next compared pro-inflammatory cytokine generation be-
tween Esrra+/+ and Esrra–/– macrophages. As shown in Figures
2A and 2B, the mRNA and protein levels of TNF, IL-1b, and
IL-6 were higher in LPS-stimulated BM-derived macrophages
(BMDM) from Esrra–/– mice, when compared to those from
Esrra+/+ cells. These results were also confirmed by knockdown
experiments using lentiviral short hairpin RNA (shRNA) specific
for Esrra (shEsrra) (data not shown). Additionally, ERRa defi-
ciency resulted in an enhancement of IKKa-IKKb phosphoryla-
tion and IkBa degradation (Figures 2C and 2D), NF-kB reporter
activity (Figure 2E), and nuclear translocation of p65 (Figure 2F),
after LPS stimulation. The posttranslational modification of
NF-kB (i.e., acetylation of NF-kB) is crucial to enhance the
DNA-binding activity of NF-kB p65 and gene activation of pro-
inflammatory mediators (Huang et al., 2010; Perkins, 2006).
LPS stimulation resulted in increased acetylation of NF-kB p65
in Esrra–/– BMDM (Figure 2G), especially in the nucleus (Figures
2H and 2I), compared to control BMDM. Together, these results
indicate that ERRa negatively regulates TLR4-induced NF-kB
signaling activation in macrophages.
Furthermore, the expression of ERRa was strongly upregu-
lated by stimulation with various TLR agonists, including
Pam3CSK4 (a ligand for TLR1 and TLR2), zymosan (TLR2 and
Dectin-1 ligand), and CpG-DNA (a TLR9 ligand) (Figure S1A).
The production of pro-inflammatory cytokines (TNF-a, IL-6, IL-
1b, IL-12p40) in response to Pam3CSK4, zymosan, and CpG
DNA was greatly increased in Esrra–/– cells compared with
Esrra+/+ cells (Figure S1B). However, TLR3-induced expression
of Tnf mRNA was not affected by ERRa deficiency (data not
shown). Thus, ERRa regulates the MyD88-dependent signaling
pathway, but not the TRIF-dependent signaling pathway.
ERRa Enhances Tnfaip3 Promoter Activity, but Inhibits
TRAF6 Ubiquitination, in Response to LPS
We next investigated the molecular mechanisms by which ERRa
negatively regulates TLR4-signaling pathways. To address this
issue, we performed global gene-expression analysis of Esrra+/+
and Esrra–/– BMDM after LPS stimulation. Microarray analysis
and quantitative real-time PCR (qRT-PCR) analysis revealed
that several genes encoding various TLR-negative regulators
including Tnfaip3 (Boone et al., 2004), Socs1 (Mansell et al.,
2006), Tank (Kawagoe et al., 2009), Senp6 (Liu et al., 2013),
and Rnf216 (Chuang and Ulevitch, 2004) were downregulated
in LPS-stimulated Esrra–/– BMDM, when compared with Esrra+/+
BMDM (Figures 3A and 3B). Moreover, these gene sets, whichImmunity 43, 80–91, July 21, 2015 ª2015 Elsevier Inc. 81
Figure 1. ERRa Is Required for Protection from LPS-Induced Lethal Shock
(A–D) Esrra+/+ and Esrra–/– mice challenged with LPS (20 mg/kg, i.p.). Data are presented as mean ± SD. (A) Survival curves (n = 11). (B) Serum concentrations of
IL-1b and IL-6. (C) qPCR analysis of Tnf, Il6, and Il1bmRNA expression in lung (left) and spleen (right) samples at 18 hr post-LPS injection (n = 3). (D) Neutrophil
counts in lung tissues (n = 3). Top, representative images (scale bar represents 50 mm); bottom, numbers of infiltrating neutrophils counted from 10 random fields.
(E–G) ERRa BM-chimeric mice (10 weeks old) injected with LPS (20 mg/kg, i.p.). Data are presented as mean ± SD. (E) qPCR (top) or semiquantitative (down;
representative images) RT-PCR analysis of Tnf and Il6 mRNA expression from spleen tissues. (F) Serum concentrations of TNF-a and IL-6 at 18 hr post-LPS
injection (n = 3). (G) Survival curves (n = 10).
*p < 0.05, **p < 0.01, ***p < 0.001, compared with control mice stimulated with LPS (log-rank test [A and G] or two-tailed Student’s t test [B–F]).are involved in the negative regulation of TLR signaling, were up-
regulated by ERRa overexpression (Figure S2A).
Consistent with the microarray data, mRNA and protein
expression of A20 (Figures 3C and 3D) were significantly attenu-
ated in LPS-stimulated Esrra–/– macrophages, when compared
with Esrra+/+ macrophages. ERRa binds to the Esrra consensus
motif (50-TNAAGGTCA-30) in order to regulate transcriptional ac-
tivity of target genes (Sladek et al., 1997). We further determined
whether the ERRa plays a role in the transcriptional activation of
Tnfaip3. Silencing and overexpression of ERRa respectively
decreased (Figure 3E) and increased (Figure 3F) Tnfaip3 pro-
moter activity in RAW264.7 cells after LPS stimulation. In addi-
tion, transfection with the mutants deleting the Esrra consensus
motif in the Tnfaip3 promoter showed a marked inhibition of
reporter gene activity (Figures 3E and 3F).82 Immunity 43, 80–91, July 21, 2015 ª2015 Elsevier Inc.Since the Tnfaip3 gene contains the Esrra consensus motif
(–520/–513) in its promoter region, we evaluated the recruitment
of ERRa to the Tnfaip3 promoter in macrophages. After LPS
stimulation, ERRa binding to the Tnfaip3 promoter region
increased significantly, whereas ERRa binding activity to the
irrelevant promoter sites (–1740/–1586) decreased markedly in
macrophages (Figure 3G). Analysis of the ERRa chromatin
immunoprecipitation (ChIP)-seq data from mouse liver in our
previous work (Chaveroux et al., 2013) revealed over 20 ERRa-
bound genes involved in TLR signaling (Figure S2B, top). ChIP
analysis and qPCR in BMDM show ERRa recruitment to Tank,
Senp6, and Rnf216 (Triad3), several known negative regulators
of TLR signaling (Figure S2B, bottom). Because A20 is a well-
known deubiquitinase in TLR signaling (Boone et al., 2004), we
examined whether ERRa deficiency affected TLR4-induced
Figure 2. ERRa Deficiency Excessively Activates TLR4-Dependent Inflammatory Responses through Enhanced Activation of NF-kB
Signaling
(A–C, E, F, H) Esrra+/+ and Esrra–/– BMDM were incubated with LPS (100 ng/mL) for the indicated times.
(A) qPCR analysis of Tnf, Il6, Il1b, and Il12p40 mRNA expression.
(B) ELISA analysis of TNF-a, IL-6, and IL-1b levels in culture supernatants.
(C) Immunoblot analysis of the indicated phosphorylated (P-) and total proteins.
(D, G, I) BMDMwere transduced with lentiviruses expressing nonspecific shRNA (shNS) or shRNA specific for Esrra (shEsrra), followed by LPS stimulation for the
indicated time periods.
(D) Immunoblot analysis of the indicated phosphorylated (P-) and total proteins.
(E) Cells were transduced with adenovirus carrying NF-kB luciferase reporter constructs before LPS stimulation. Luciferase assays were performed based on
normalization to the b-galactosidase activity.
(F) Immunofluorescence microscopy analysis of NF-kB p65 nuclear translocation. Left, representative images; right, quantitation of p65 nuclear translocation.
(G) Immunoblot analysis of the indicated acetylated (AC-) and total proteins.
(H and I) Immunoblot analysis of the indicated acetylated (AC-) and total proteins in the cytoplasmic (Cyto) and nuclear (Nu) extracts. Lamin B1 and b-actin are
used as quality and loading controls.
Data are representative of three independent experiments and are presented as means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, compared with control cultures
(two-tailed Student’s t test). Also see Figure S1.TRAF6 polyubiquitination. We found that K63-linked poly-
ubiquitination of TRAF6 increased, whereas K48-linked poly-
ubiquitination decreased, in Esrra–/– BMDMafter LPS stimulation
(Figures 3H–3J). Together, ERRa inhibits TLR signaling via tran-
scriptional activation of the Tnfaip3 gene, thus inhibiting K63-
linked polyubiquitination of TRAF6.
ERRa Regulates TLR4-Mediated Glycolytic Metabolism,
NF-kB p65 Acetylation, and HIF1a Stabilization
On the basis of the findings that ERRa is required for mitochon-
drial biogenesis and function of OXPHOS (Hong et al., 2013;
Sonoda et al., 2007), we assessed glycolysis and the NAD+/NADH ratio in macrophages. When compared to Esrra+/+
BMDM, Esrra–/– BMDM showed a marked inhibition of the
NAD+/NADH ratio from 91.8% to 51.3% (at 8 and 18 hr, respec-
tively) (Figure 4A), an increase of lactate levels (Figure 4B) after
LPS stimulation. In addition, the extracellular acidification rate
(ECAR), an indirect indicator of lactate production and enhanced
glycolytic metabolism (Doherty and Cleveland, 2013), levels
were significantly elevated in Esrra–/– BMDM at 8 hr (Figure 4C,
top) and 18 hr (Figure 4C, bottom) of LPS stimulation. However,
there was no significant difference between Esrra+/+ and Esrra–/–
cells in LPS-induced ATP production (Figure 4D). To clearly
establish the origin of ATP generation, we replaced glucoseImmunity 43, 80–91, July 21, 2015 ª2015 Elsevier Inc. 83
Figure 3. ERRa Promotes A20 Transcriptional Activation, and Inhibits TRAF6 Ubiquitination
(A, B, D, I, and J) Esrra+/+ and Esrra–/– BMDM were incubated with LPS (100 ng/mL) for the indicated times.
(A) Heat map representing LPS-responsive gene-expression profiles including TLR-negative regulators in Esrra+/+ and Esrra–/– BMDM. Each column in the heat
map represents the ratio of normalized expression.
(B) qPCR analysis of Tnfaip3, Socs1, Traf1, Tollip, Cyld, Tank, Senp6, and Rnf216 mRNA expression.
(C and H) BMDM were transduced with shNS or shEsrra, followed by LPS stimulation for the indicated time periods. Semiquantitative RT-PCR (top) or qPCR
(bottom) analysis for Tnfaip3 expression. b-actin served as loading controls.
(D) Immunoblot analysis of the indicated proteins.
(E and F) RAW264.7 cells were transduced/transfected before LPS stimulation (6 hr). Luciferase assays were performed based on normalization to the
b-galactosidase activity. Top shows diagrams that show deletions (E) or point mutations (F) of ERRa-binding sites in the Tnfaip3 promoter constructs used for the
luciferase assay.
(E) RAW264.7 cells transduced with shNS or shEsrra were transfected with a Tnfaip3-luciferase reporter construct carrying wild-type (WT) or deleted (MT)
ERRa-binding site. Inset shows knockdown efficiency of ERRa protein.
(F) RAW264.7 cells were transfected with a Tnfaip3-luciferase reporter construct (WT, Tnfaip3WT;MT, Tnfaip3 carrying point mutations in the ERRa-binding site)
in the presence or absence of the plasmid encoding flag-tagged murine ERRa (pcDNA-Esrra). Inset shows transfection efficiency of ERRa plasmid.
(G) ChIP assays were conducted in BMDM stimulated with LPS (90 or 180 min). Immunoprecipitations were performed using Abs specific to ERRa, and con-
ventional RT-PCR (top) or qPCR analysis (bottom) using primers specific to the Tnfaip3 promoter.
(H) Immunoprecipiation of TRAF6 from LPS-stimulated control BMDM (shNS), and BMDM in which ERRawas knocked down (shEsrra), followed by immunoblot
analysis with anti-ubiquitin (Ub) or anti-TRAF6. Bottom shows immunoblot analysis of ERRa or TRAF6 in lysates without precipitation.
(legend continued on next page)
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with galactose in LPS-treated cells. LPS-induced ATP genera-
tion was effectively blocked by galactose in Esrra–/– cells, sup-
porting the contention that ATP generation in this context is
glycolysis-dependent (Figure 4E). Consistent with this, ChIP-
qPCR data showed that several genes involved in glycolysis
including Pdk4 (an inhibitor of the conversion of pyruvate to
acetyl-CoA) and Slc2a1 (glucose transporter 1), was elevated
in Esrra–/– BMDM compared with WT BMDM (Figure S2B,
bottom).
Sirtuin 1 (SIRT1) is an NAD+-dependent deacetylase that is
critically involved in the regulation of NF-kB-mediated inflamma-
tory responses via the deacetylation of p65/RelA on lysine 310
(Chen et al., 2005; Yang et al., 2012; Yang et al., 2006; Yeung
et al., 2004).We evaluated the influence of ERRa on SIRT1-medi-
ated deacetylation of NF-kB p65. Following LPS stimulation,
cellular NAD+ levels (Figure S3A) and SIRT1 mRNA and protein
expression were decreased in Esrra–/– macrophages compared
to those from control macrophages (Figures 4F, 4G, and S3B).
Simultaneously, ERRa deficiency in macrophages led to
enhanced acetylation of NF-kB p65 on Lys310 after LPS stimu-
lation (Figures 4F and S3B). In addition, ERRa overexpression re-
sulted in Sirt1 promoter induction, increasing the reporter gene
activities 2.4-fold (Figure 4H). However, a mutation within the
Esrra consensus motif of the Sirt1 promoter (Figure 4H, top)
decreased the response to LPS in RAW264.7 cells (Figure 4H).
Taken together, these findings suggest that the Sirt1 promoter
is responsive to ERRa and that the identified ERR response
element (ERRE) contributes to the induction by ERRa.
Previous studies have demonstrated that HIF1a is an impor-
tant activator of aerobic glycolysis that is stabilized by the
LPS-induced metabolite succinate (Tannahill et al., 2013).
Further investigation of LPS-induced protein expression of
HIF1a confirmed that HIF1a is upregulated and stabilized in
Esrra–/– macrophages (Figure 4I). Silencing of Hif1a in macro-
phages indicated that LPS-induced HIF1a expression is essen-
tial for IL-1b production after LPS stimulation (Figure 4J), a result
that is partially consistent with data from previous studies (Tan-
nahill et al., 2013). Together, these results indicate that ERRa
is required for controlling glycolysis, SIRT1-dependent NF-kB
p65 acetylation, and HIF1a stabilization, all of which lead to
enhanced inflammatory responses in macrophages in response
to TLR4 stimulation.
ERRa Modulates Expression of Genes Regulating
OXPHOS and Mitochondrial Biogenesis in Response
to LPS
To evaluate whether ERRa deficiency affects mitochondrial
function and biogenesis in macrophages, we next performed
an extracellular flux analysis. LPS stimulation led to a character-
istic decline in the oxygen consumption rate (OCR) in WT BMDM
(Figure 5A), as previously shown (Tannahill et al., 2013).
Compared to Esrra+/+ BMDM,Esrra–/– BMDMexhibited a greater
reduction in baselineOCRand carbonyl cyanide 3-chlorophenyl-
hydrazone (CCCP)-induced uncoupling during OXPHOS, both in(I and J) Cell lysates were subjected to immunoprecipitation with anti-TRAF6 an
antibody (I) or anti-Ub-K48-specific antibody (J).
Data are representative of three independent experiments and are presented as m
(two-tailed Student’s t test). Also see Figure S2.the presence and absence of LPS (Figure 5A). In addition, LPS
treatment of Esrra+/+ BMDM upregulated the protein expression
of mitochondrial respiratory chain complexes I (NDUFA9), IV
(COX4), and V (ATP5A1) (Figure 5B). Notably, the expression of
most proteins of the respiratory chain complexes I–V was signif-
icantly diminished in Esrra–/– BMDM, at rest and at each time
point after LPS stimulation compared to those in Esrra+/+
BMDM (Figure 5B).
The microarray expression data showed that ERRa contrib-
utes to the macrophage induction of genes involved in
mitochondrial biogenesis and metabolic functions (e.g., mito-
chondrial respiration, OXPHOS, ATP synthesis, tricarboxylic
acid (TCA) cycle, and fatty acid b-oxidation; Figure S4). We
further examined the gene and protein expression related to
mitochondrial biogenesis in Esrra+/+ and Esrra–/– BMDM before
and after LPS stimulation. The expression of both nuclear
respiratory factor (NRF)-1 and TFAM was affected by the
absence of ERRa. In addition, after LPS stimulation, the genes
and proteins involved in mitochondrial biogenesis, such as
peroxisome proliferator-activated receptor gamma coactivator
1-alpha (PGC1a), PGC1b, NRF-1, and TFAM, were significantly
downregulated in Esrra–/– BMDM compared to Esrra+/+ BMDM
(Figures 5C and 5D). Moreover, LPS-induced mitochondrial
DNA content (Figure 5E) and mass (Figure 5F) substantially
decreased in Esrra–/– BMDM compared to Esrra+/+ BMDM,
suggesting that ERRa is required for enhancement of mito-
chondrial biogenesis (Figures 5E and 5F). Together, these
data indicate that ERRa contributes to mitochondrial biogen-
esis, OXPHOS expression, and function in macrophages during
TLR4 signaling.
TLR4 Activates Induction of ERRa via the Ca2+-
CaMKKb-AMPK Pathway and MyD88 Signaling
Because TLR signaling induces expression of ERRa mRNA
and protein (Figures 3C, 6A, and S1A), we next examined the
molecular mechanism occurs in macrophages. Previous studies
reported a connection between AMPK and ERRa in cardiac
myocytes (Hu et al., 2011). Indeed, presentation of AMPK inhib-
itor (compound C) to macrophages markedly inhibited LPS-
induced ERRa expression (Figure 6B). Overexpression of a
constitutively active AMPK upregulated (Figures 6C and S5A),
whereas transfection of dominant negative AMPK or knocking
down of Prkaa1 effectively attenuated, LPS-induced ERRa
mRNA and protein expression in macrophages (Figures 6C
and 6E; Figures S5A and S5B). Further, pharmacological inhibi-
tion or silencing of Ca2+/calmodulin-dependent protein kinase
kinase b (CaMKKb), an upstream kinase of AMPK (Hardie,
2007), significantly attenuated ERRa expression in macro-
phages (Figures 6D, 6E, and S5B). However, blockade of
LKB1, which also activates AMPK in macrophages (Hardie,
2007), did not inhibit LPS-induced ERRa expression (Figures
6F and S5C). Moreover, pharmacological inhibition of intracel-
lular calcium release blocked LPS-induced ERRa expression
and AMPK activation in macrophages (Figures S5D–S5F).tibody and analyzed by immunoblotting with anti-ubiquitin (Ub)-K63-specific
eans ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, compared with control cultures
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Figure 4. Esrra–/– Macrophages Enhances Aerobic Glycolysis, Hyperacetylation of NF-kB p65, and HIF1a Stabilization after LPS Stimulation
(A–D, F, G, I) Esrra+/+ and Esrra–/– BMDM were incubated with LPS (100 ng/mL) for the indicated times.
(A) NAD+/NADH ratio.
(B) Lactate production.
(C) The real-time rates of extracellular acidification rate (ECAR) were analyzed as an indicator of glucose oxidation. LPS stimulation for 8 hr (top) or 18 hr (bottom).
(D) Total ATP levels measured by the luciferin/luciferase method.
(E) Total ATP levels from Esrra–/– BMDM stimulated with LPS (100 ng/mL) for 18 hr, prior to culturing in glucose- or galactose-containing medium for 15 min.
(F) Immunoblot analysis of the indicated acetylated (AC-) and total proteins.
(G) qPCR analysis for Sirt1 mRNA expression.
(H) RAW264.7 cells were transfected with a Sirt1-luciferase reporter construct (WT, Sirt1WT; MT, Sirt1 carrying point mutations in the ERRa-binding site) in the
presence or absence of the plasmid encoding flag-tagged murine ERRa (pcDNA-mEsrra). Cells were then stimulated with LPS (6 hr), followed by luciferase
assays based on normalization to the b-galactosidase activity. Top shows diagrams that show point mutations (E) of ERRa-binding sites in the Sirt1 promoter
constructs used for the luciferase assay.
(I) Immunoblot analysis of the indicated proteins.
(J) BMDM were transduced with shNS or shRNA specific for Hif1a (shHif1a), followed by LPS stimulation for the indicated time periods. Top shows knockdown
efficiency of HIF1a protein; Bottom shows ELISA analysis for IL-1b production.
Data are representative of three independent experiments and are presented as means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, compared with control cultures
(two-tailed Student’s t test). Also see Figure S3.PGC1 family members are critical for transcriptional control of
mitochondrial biogenesis, and their activity is linked to the en-
ergy sensor AMPK (Scarpulla, 2011). We detected that AMPK
activation was required for the induction of PGC1a (Figure S5G),
which in turn promoted ERRa expression in response to LPS
(Figures 6G and S5H). Indeed, PGC1a overexpression increased
LPS-induced, ERRa-dependent transcriptional activity, in mac-86 Immunity 43, 80–91, July 21, 2015 ª2015 Elsevier Inc.rophages (Figure 6H). These data confirmed that the previously
identified requirement of PGC1a for autoregulation of ERRa
(Laganie`re et al., 2004) is also valid in macrophages. MyD88
and TRIF are important adaptors of TLR4-triggered activation
of NF-kB signaling in the innate immune response (Kawai
et al., 1999). LPS-induced expression of ERRa was partially
abrogated in MyD88-deficient cells (Figure 6I), but not in
Figure 5. ERRa Deficiency Impairs Mitochondrial Respiration and Biogenesis during TLR4 Signaling
(A–F) Esrra+/+ and Esrra–/– BMDM were incubated with LPS (100 ng/mL) for the indicated times.
(A) Real-time measurement of oxygen consumption rate (OCR) was analyzed by sequential treatment with oligomycin, carbonyl cyanide 3-chlorophenylhy-
drazone (CCCP), and rotenone, as an indicator of oxidative metabolism.
(B) Immunoblot analysis of the indicated proteins.
(C) qPCR analysis for Nrf1, Ppargc1a (Pgc1a), Ppargc1b (Pgc1b), and Tfam expression.
(D) Immunoblot analysis of the indicated proteins.
(E) The mtDNA content was measured by qPCR analysis, and normalized by a nuclear DNA content.
(F) Measurements of mitochondrial mass using MitoTracker green with flow cytometry.
Data are representative of three independent experiments and are presented as means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, compared with control cultures
(two-tailed Student’s t test). Also see Figure S4.TRIF-deficient cells (Figure S5I). These data suggest that the
Ca2+-CaMKKb-AMPK-PGC1a and TLR4-MyD88 signaling path-
ways are required for LPS-induced induction of endogenous
ERRa in macrophages.
DISCUSSION
Here we demonstrated that ERRa regulates TLR signaling, via
at least two mechanisms: dissociation of adaptor complexes
through A20-mediated regulation of TRAF6 polyubiquitination
and posttranslational regulation of NF-kB p65 acetylation, which
was modulated by SIRT1 activation. We further showed that
ERRa is involved in promoting mitochondrial respiratory function
and biogenesis required to drive themore energy-efficient oxida-
tive metabolic pathways during TLR-induced inflammation.
Notably, BM-derived ERRa was required for controlling inflam-
matory responses during endotoxin stimulation in vivo. It is note-
worthy that ERRa associates with distinct chromatin binding
sites in the promoter region of Tnfaip3, and that ERRa is required
for Tnfaip3 promoter activity of genes containing ERRa-binding
elements. A20 deubiquitinates the signaling molecule TRAF6,
thus disrupting ubiquitin-conjugated enzyme complexes and
terminating TLR-induced NF-kB signaling and inflammatory re-sponses (Boone et al., 2004; Shembade et al., 2010). Previous
studies showed that ERRa null livers display increased NF-kB-
dependent cytokine gene expression in the Kupffer cells, an
effect associated with the disruption of ERRa-dependent regula-
tion of the NF-kB inhibitor IkBa (Hong et al., 2013). Combined
with the current findings, ERRa may modulate IkBa and other
negative regulators (e.g., Tank, Senp6, Rnf216; see Figures 3B
and S2) of the TLR-induced inflammatory response in macro-
phages (proposed mechanisms, Figure S6).
During inflammation, the early phase responses primarily
require glycolysis, whereas fatty acid oxidation via NAD+-depen-
dent processes plays a more dominant role in later phases
(Everts et al., 2014; Liu et al., 2012b; Liu et al., 2011). This study
elucidated another key role of ERRa in the molecular checkpoint
of the immune cell metabolism through the regulation of NAD+-
dependent processes, thus affecting inflammatory responses
in immune cells. Emerging evidence indicates that the SIRT fam-
ily of NAD+ sensors is critically involved in linkingmetabolism and
inflammation (Liu et al., 2012a; Liu et al., 2011; Yeung et al.,
2004). The increased NAD+ levels brought about by the Nampt
salvage pathway in mammalian cells activate SIRT1 to deacety-
late and inactivate NF-kB p65, thereby terminating inflammatory
responses (Liu et al., 2011; Yeung et al., 2004). Aside from theImmunity 43, 80–91, July 21, 2015 ª2015 Elsevier Inc. 87
Figure 6. TLR4 Activation Induces Macrophage ERRa via the Ca2+-CaMKKb-AMPK and TLR4-MyD88 Signaling
(A) Immunoblot analysis of ERRa in BMDM after LPS (100 ng/mL) stimulation for the indicated times.
(B and D) Immunoblot analysis of ERRa in BMDM after LPS stimulation (100 ng/mL; 6 hr) in the presence or absence of the AMPK inhibitor compound C (CompC;
5, 10, 25 mM) (B) or the Ca2+/CaMKII inhibitor KN93 (5, 10, 25 mM) (D).
(C, E–G) BMDM were transduced with Ad-GFP, Ad-CA-AMPK, or Ad-DN-AMPK (C); shNS, shRNA specific for Camk2 (shCamk2), or for Ampka (shAmpk) (E);
transduced with shNS or shRNA specific for Lkb1 (shLkb1) (F); shNS or shRNA specific for Ppargc1a (shPgc1a) (G) prior to stimulation with LPS (100 ng/mL) for
6 hr. (C Left, E Top, F Left, and G) Immunoblot analysis of the indicated proteins; (C Right, E Bottom, F Right) qPCR analysis of Esrra.
(H) THP-1 cells were transfected with Esrra-luciferase reporter constructs containing 3 copies of the Esrra element (3X) or a synthetic mutant in which the region
containing the Esrra element is absent (DESRRA), in the presence or absence of the plasmid encoding flag-tagged human PPARGC1A (pcDNA-hPGC1a). Cells
were then treated with LPS for 6 hr, followed by luciferase assays, which were normalized to b-galactosidase activity. Top shows diagrams that show Esrra-
luciferase reporter constructs used for the luciferase assay.
(I) Immunoblot analysis of ERRa in Myd88+/+ and Myd88–/– BMDM after LPS (100 ng/mL) stimulation for the indicated times.
Data are representative of three independent experiments and are presented as means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, compared with control cultures
(two-tailed Student’s t test). Also see Figure S5.findings that ERRa is required for preventing NAD+ depletion, we
unexpectedly found that ERRa promotes the transcriptional acti-
vation of Sirt1 during inflammation. Additionally, we showed that
HIF1a stabilization is elevated in Esrra–/– macrophages. These
findings might be due to SIRT1 inactivation in ERRa deficiency,
based on the previous findings that SIRT1 represses HIF1a-tar-
get genes through binding and deacetylating HIF1a (Lim et al.,
2010). Further, we confirmed the central role of HIF1a in LPS-
induced IL-1b expression. In accordancewith this, previous find-
ings reported that HIF1a stabilization leads to increased IL-1b
secretion by macrophages (Tannahill et al., 2013).
In response to pathogenic or dangerous stimuli, immune cells
undergo metabolic reprogramming, which shapes the innate
immune responses to invading pathogens or tissue damage
(Ganeshan and Chawla, 2014; Martinez et al., 2013). Indeed,
mitochondrial biogenesis in response to inflammation is benefi-
cial to the host in terms of preserving metabolic function and cell
viability, as well as to assist with resolution of inflammation (Pian-
tadosi and Suliman, 2012). Data presented here reveal that ERRa88 Immunity 43, 80–91, July 21, 2015 ª2015 Elsevier Inc.contributes to mitochondrial biogenesis and OXPHOS function
in TLR-activated macrophages through the activation of
genes involved in these processes. These data are in partial
agreement with previous studies showing that ERRa is essen-
tially involved in the expression of numerous genes related to
mitochondrial respiratory function (Sonoda et al., 2007). The
same study also showed that IFN-g-induced ERRa activation
is mediated through PGC1b (Sonoda et al., 2007). In the adapta-
tion phase of inflammatory responses, PGC1a and -b promote
the expression of multiple genes including NRF-1 and NRF-2,
which play roles in mitochondrial biogenesis and OXPHOS
(Gerhart-Hines et al., 2007; Vercauteren et al., 2008). A previous
study demonstrated that LPS stimulation leads to NRF-1 gene
induction through co-regulation of NF-kB and CREB signaling,
leading to attenuation of inflammatory damage by linking mito-
chondrial biogenesis (Suliman et al., 2010). Together, these
data indicate that ERRa-dependent activation of genes involved
in mitochondrial biogenesis and respiratory function could
contribute toward ameliorating mitochondrial damage and
maintaining mitochondrial homeostasis, thus inhibiting exces-
sive inflammatory responses during TLR signaling.
TLR signaling in macrophages leads to an initial reduction,
followed by a delayed elevation of AMPK activation (Yuk
et al., 2011). Increased AMPK activation enhances SIRT1 activ-
ity by increasing cellular NAD+ levels, resulting in activation of
PGC1 to promote mitochondrial biogenesis and induction of
the metabolic shift to fatty acid oxidation (Canto´ and Auwerx,
2009; Lin, 2009; Scarpulla, 2011). The PGC1a regulatory
network is indicative of a critical role for ERRa in orchestrating
mitochondrial biogenesis and energy homeostasis in many tis-
sues, to serve diverse biological functions (Scarpulla, 2011).
Notably, we found that LPS stimulation induced intracellular
Ca2+-dependent AMPKa phosphorylation, which is required
for the expression of PGC1a, and that silencing of PGC1a
diminished the TLR-induced increase in ERRa gene ex-
pression. The current study provides evidence for a new
function of AMPK signaling as a negative feedback mechanism
during inflammation through induction of the PGC1a/ERRa
pathway (see Figure S6), thus driving mitochondrial biogenesis
according to the metabolic requirements during inflammatory
stresses.
In summary, our results suggest that ERRa is a novel regulator
of the TLR-induced inflammatory response, with the unique
capacity to modulate (1) Tnfaip3 transcriptional induction and
(2) p65 acetylation through metabolic reprogramming via
enhancement of mitochondrial function. Through these regula-
tory processes, ERRa might control the overall inflammatory
response to prevent excessive damage to the host. These find-
ings provide a potential new therapeutic strategy for the treat-
ment of systemic inflammatory response syndrome.
EXPERIMENTAL PROCEDURES
For mouse model of sepsis and bone marrow transplantation; reagents, anti-
bodies, primer and plasmid construction; adenovirus production; lentiviral
shRNA generation and transduction of primary cells; measurement of ATP
production; immunoprecipitation and in vivo ubiquitination assays; and ChIP
assay, luciferase assay, fluorescence microscopy, histology, and immunohis-
tochemistry, see Supplemental Experimental Procedures.
Cell Preparation
BMDM were differentiated for 5–7 days in medium containing macrophage
colony-stimulating factor, as described previously (Yuk et al., 2011). The cul-
ture medium consisted of Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1 mM so-
dium pyruvate, 50 U/mL penicillin, 50 mg/mL streptomycin, and 5 3 105 M
2-mercaptoethanol. The mouse macrophage cell line RAW264.7 and
HEK293 cells were purchased from the American Type Culture Collection
and grown in DMEM/glutaMAX (Life Technologies) supplemented with
10% FBS.
RNA Extraction, qPCR, Semiquantitative RT-PCR, Western Blotting,
Subcellular Fractionation, and Enzyme-Linked Immunosorbent
Assays
RNA extraction, real-time quantitative PCR, and semiquantitative RT-PCR
were performed as described previously (Yuk et al., 2011). The sequences
of the primers used are described in the Supplemental Experimental Proce-
dures. For Western blotting, the primary antibodies were used at a 1:1000 dilu-
tion. Themembraneswere developed using a chemiluminescence assay (ECL;
Pharmacia-Amersham) and were subsequently exposed to chemilumines-
cence film (Pharmacia-Amersham). Nuclear and cytosolic protein extracts
were prepared using the Nuclear Extraction Kit (Active Motif) according tothe manufacturer’s instructions. In the sandwich ELISA, serum and cell culture
supernatants were analyzed using DuoSet antibody pairs (BD PharMingen) for
detecting IL-6, IL-1b, IL-12p40, and TNF-a.
Assessment of Mitochondrial DNA Content and Mass
For the quantification of mitochondrial content, we measured the mito-
chondrial (mt) to nuclear (n) DNA ratio. Pyruvate kinase was used as a
marker for nDNA and NADH dehydrogenase subunit 1 (ND-1) for mtDNA.
Real-time PCR reactions were performed according to the manufacturer’s in-
structions (SYBR green PCR master mix; QIAGEN), and thermal cycling was
performed in a Rotor gene 6000 instrument (QIAGEN). The mtDNA content
was normalized to that of nuclear DNA. To evaluate mitochondrial mass,
we stained the cells with MitoTracker Green FM (Life Technologies), which
stains mitochondrial matrix protein, irrespective of the membrane potential,
and thus provides an accurate assessment of mitochondrial mass. Fluores-
cence intensity was measured by flow cytometry and confocal laser-
scanning microscopy, and the values were corrected for the total protein
concentration.
Metabolic Assays
Lactate levels in the medium were determined using a Lactate Assay Kit
(Biovision), according to the manufacturer’s instructions. Briefly, the cells
were stimulated with LPS for the indicated periods and the supernatants
were then collected and stored at –80C to inactivate lactate dehydroge-
nase. The reaction mix was added to the samples, which were then
analyzed on a microplate reader (OD570nM). The NAD
+/NADH ratio was
measured from whole-cell lysates using a NAD+/NADH Quantification Color-
imetric Kit (BioVision), according to the manufacturer’s instructions. For real-
time analysis of the extracellular acidification rate (ECAR) and the oxygen
consumption rate (OCR), BMDM were analyzed using an XF-24 Extracellular
Flux Analyzer (Seahorse Bioscience). In brief, BMDM were plated in XF-24
cell culture microplates (2 3 105 cells/well in 200 mL) and then stimulated
with LPS for the indicated time periods. At the indicated time points, the
medium was removed, and the cells were washed and analyzed in XF
Running Buffer (unbuffered RPMI, 10 mM glucose, 10% FCS, 100 U/mL
penicillin/streptomycin, 2 mM L-glutamine, and 20 ng/mL of GM-CSF) ac-
cording to the manufacturer’s instructions to analyze real-time values of
OCR and ECAR. Where indicated, ECAR and/or OCR were analyzed in
response to 2 mg/mL oligomycin, 5 mM CCCP, and 2 mM rotenone (all from
Sigma-Aldrich).
Statistical Analyses
Differences between averages were analyzed using a two-tailed Student’s
t test. The significance of differences in survival was determined using a
log-rank test.
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